Current knowledge and future directions of the selective epidermal growth factor receptor inhibitors erlotinib (Tarceva (R)) and gefitinib (Iressa (R))

W.S. Siegel-Lakhai; J.H. Beijnen; J.H.M. Schellens

Current knowledge and future directions of the selective epidermal growth factor receptor inhibitors erlotinib (Tarceva (R)) and gefitinib (Iressa (R))

W.S. Siegel-Lakhai, J.H. Beijnen, J.H.M. Schellens

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	579-589
Number of pages	11
Journal	Oncologist
Volume	10
Issue number	8
Publication status	Published - 2005

Cite this

@article{6cbbbccdf0eb4082873b6d7007efb8c1,

title = "Current knowledge and future directions of the selective epidermal growth factor receptor inhibitors erlotinib (Tarceva (R)) and gefitinib (Iressa (R))",

author = "W.S. Siegel-Lakhai and J.H. Beijnen and J.H.M. Schellens",

year = "2005",

language = "Undefined/Unknown",

volume = "10",

pages = "579--589",

journal = "Oncologist",

issn = "1083-7159",

publisher = "Oxford University Press",

number = "8",

}